Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tolasure by Biomendics for Epidermolysis Bullosa: Likelihood of Approval
Tolasure is under clinical development by Biomendics and currently in Phase II for Epidermolysis Bullosa. According to GlobalData, Phase II...